Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma

Despite long-standing efforts to enhance care for chronic asthma, symptomatic treatments remain the only option to manage this highly prevalent and debilitating disease. We demonstrate that key pathology of allergic asthma can be almost completely resolved in a therapeutic manner by inhaled gene the...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Adriana L., de Oliveira, Gisele P., Kim, Namho, Cruz, Fernanda F., Kitoko, Jamil Z., Blanco, Natalia G., Martini, Sabrina V., Hanes, Justin, Rocco, Patricia R. M., Suk, Jung Soo, Morales, Marcelo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286682/
https://www.ncbi.nlm.nih.gov/pubmed/32577505
http://dx.doi.org/10.1126/sciadv.aay7973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286682/
https://www.ncbi.nlm.nih.gov/pubmed/32577505
http://dx.doi.org/10.1126/sciadv.aay7973

Ejemplares similares